Cargando…
Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer
BACKGROUND: The B3GNT6 protein is a member of the O-GlcNAc transferase (OGT) family and is responsible for the production of the core 3 structure of O-glycans. It is generally expressed in the gastrointestinal (GI) tract; however, its clinical significance in colorectal cancer remains largely unexpl...
Autores principales: | Xiao, Shihan, Yang, Chen, Zhang, Yang, Lai, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988341/ https://www.ncbi.nlm.nih.gov/pubmed/35387659 http://dx.doi.org/10.1186/s12957-022-02561-x |
Ejemplares similares
-
STXBP6 and B3GNT6 Genes are Associated With Selective IgA Deficiency
por: Lim, Che Kang, et al.
Publicado: (2021) -
B3GNT5 is a novel marker correlated with stem‐like phenotype and poor clinical outcome in human gliomas
por: Jeong, Hang Yeon, et al.
Publicado: (2020) -
Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness
por: Miao, Zhaorui, et al.
Publicado: (2022) -
B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer
por: Zhang, Weijing, et al.
Publicado: (2015) -
B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma
por: Wu, Yuanzhou, et al.
Publicado: (2022)